# FDA recall D-0287-2023

> **Sentara Infusion Services** · Class II · drug recall initiated 2022-12-27.

## Product

DAPTOMYCIN (a) 400MG IN NS 20ML, (b) 550MG IN NS 27.5ML, antibiotic, Rx only, used with a home pump. Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320

## Reason for recall

Lack of sterility assurance

## Distribution

Dispensed to Patients Nationwide.

## Key facts

- **Recall number:** D-0287-2023
- **Recalling firm:** Sentara Infusion Services
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-27
- **Report date:** 2023-02-22
- **Termination date:** 2026-02-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chesapeake, VA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0287-2023

## Citation

> AI Analytics. FDA recall D-0287-2023. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0287-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*